These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2408908)

  • 1. Characterization of spinal actions of four substance P analogues.
    Couture R; Yashpal K; Henry JL; Escher E; Regoli D
    Eur J Pharmacol; 1985 Mar; 110(1):63-9. PubMed ID: 2408908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of substance P analogues in the rat tail-flick test.
    Couture R; Escher E; Regoli D
    Eur J Pharmacol; 1987 Feb; 134(3):355-9. PubMed ID: 2436927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal actions of substance P analogues on cardiovascular responses in the rat: a structure-activity analysis.
    Couture R; Gupta A; Kérouac R; Escher E; Regoli D
    Can J Physiol Pharmacol; 1987 Mar; 65(3):412-8. PubMed ID: 2438022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of substance P analogues on spinal dorsal horn neurons.
    Randic M; Jeftinija S; Urban L; Raspantini C; Folkers K
    Peptides; 1988; 9(3):651-60. PubMed ID: 2458574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini.
    Jensen RT; Jones SW; Lu YA; Xu JC; Folkers K; Gardner JD
    Biochim Biophys Acta; 1984 Jun; 804(2):181-91. PubMed ID: 6202326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do local vasomotor effects elicit the motor deficits induced by intrathecally applied substance P antagonists in the rat?
    Barber A; Wild A; Wedel R
    Neurosci Lett; 1987 Sep; 80(2):219-23. PubMed ID: 2446208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The substance P receptor subtype modulating catecholamine release from adrenal chromaffin cells.
    Boksa P; Livett BG
    Brain Res; 1985 Apr; 332(1):29-38. PubMed ID: 2581649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural and antinociceptive effects of intrathecally injected substance P analogues in mice.
    Post C; Folkers K
    Eur J Pharmacol; 1985 Jul; 113(3):335-43. PubMed ID: 2412846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.
    Bailey SJ; Featherstone RL; Jordan CC; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):79-85. PubMed ID: 2420403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LH-RH analogue acts as substance P antagonist by inhibiting spinal cord vasomotor responses.
    Takano Y; Sawyer WB; Sanders NL; Loewy AD
    Brain Res; 1985 Jul; 337(2):357-61. PubMed ID: 2411337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
    Keeler JR; Charlton CG; Helke CJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and segmental distribution of 125I-Bolton-Hunter-labeled substance P binding sites in rat spinal cord.
    Charlton CG; Helke CJ
    J Neurosci; 1985 May; 5(5):1293-9. PubMed ID: 2582102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of [D-Pro2, D-Phe7, D-Trp9]-substance P and [D-Trp7,9]-substance P as tachykinin partial agonists in the rat colon.
    Bailey SJ; Jordan CC
    Br J Pharmacol; 1984 Jun; 82(2):441-51. PubMed ID: 6203595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ability of various substance P antagonists to inhibit action of bombesin.
    Jensen RT; Heinz-Erian P; Mantey S; Jones SW; Gardner JD
    Am J Physiol; 1988 Jun; 254(6 Pt 1):G883-90. PubMed ID: 2454035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of substance P analogs on neurokinin 1 receptor agonists in the mouse spinal cord.
    Sakurada T; Yamada T; Tan-no K; Manome Y; Sakurada S; Kisara K; Ohba M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):205-10. PubMed ID: 1717679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal administration of a substance P receptor antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of action.
    Helke CJ; Phillips ET; O'Neill JT
    J Pharmacol Exp Ther; 1987 Jul; 242(1):131-6. PubMed ID: 2441024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P analogues containing D-histidine antagonize the behavioural effects of intrathecally co-administered substance P in mice.
    Sakurada T; Yamada T; Sakurada S; Kisara K; Ohba M
    Eur J Pharmacol; 1989 Dec; 174(2-3):153-60. PubMed ID: 2483548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance p analogue blocks sp-induced facilitation of a spinal nociceptive reflex.
    Yashpal K; Henry JL
    Brain Res Bull; 1984 Oct; 13(4):597-600. PubMed ID: 6084544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive and neurotoxic actions of substance P analogues in the rat's spinal cord after intrathecal administration.
    Post C; Paulsson I
    Neurosci Lett; 1985 Jun; 57(2):159-64. PubMed ID: 2412191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.